Search research articles
Contact Us
Filters
Showing results (151-160 of 324) with videos related to
Page
of 33
Sort By:
Atherosclerosis
|
August 1, 1994
Familial lipoprotein disorders and premature coronary artery disease
E J Schaefer, J J Genest, J M Ordovas, et al.
Journal of Clinical Epidemiology
|
April 1, 1996
Tracking of glycated hemoglobin in the original cohort of the Framingham Heart Study
J B Meigs, D M Nathan, L A Cupples, et al.
Archives of Internal Medicine
|
July 12, 1993
Healthy People 2000. The rationale and potential efficacy of preventive nutrition in heart disease: the Framingham Offspring-Spouse Study
B M Posner, L A Cupples, D Gagnon, et al.
JAMA
|
March 2, 1990
How reliably can compact chemistry analyzers measure lipids?
H W Kaufman, J R McNamara, K M Anderson, et al.
The New England Journal of Medicine
|
November 5, 1987
Hip fracture and the use of estrogens in postmenopausal women. The Framingham Study
D P Kiel, D T Felson, J J Anderson, et al.
Journal of Lipid Research
|
April 1, 1987
Apolipoprotein E isoform phenotyping methodology and population frequency with identification of apoE1 and apoE5 isoforms
J M Ordovas, L Litwack-Klein, P W Wilson, et al.
American Heart Journal
|
September 1, 1990
Diabetes, fibrinogen, and risk of cardiovascular disease: the Framingham experience
W B Kannel, R B D'Agostino, P W Wilson, et al.
Archives of Internal Medicine
|
May 1, 1989
Is coffee consumption a contributor to cardiovascular disease? Insights from the Framingham Study
P W Wilson, R J Garrison, W B Kannel, et al.
Annals of Internal Medicine
|
June 10, 1998
Metabolic risk factors worsen continuously across the spectrum of nondiabetic glucose tolerance. The Framingham Offspring Study
J B Meigs, D M Nathan, P W Wilson, et al.
Diabetes
|
February 1, 1992
Association of HbA1c with prevalent cardiovascular disease in the original cohort of the Framingham Heart Study
D E Singer, D M Nathan, K M Anderson, et al.
Page
of 33
Search research articles
Search
Showing results (151-160 of 324) with videos related to
Sort By:
Page
of 33
Atherosclerosis
|
August 1, 1994
Familial lipoprotein disorders and premature coronary artery disease
E J Schaefer, J J Genest, J M Ordovas, et al.
Journal of Clinical Epidemiology
|
April 1, 1996
Tracking of glycated hemoglobin in the original cohort of the Framingham Heart Study
J B Meigs, D M Nathan, L A Cupples, et al.
Archives of Internal Medicine
|
July 12, 1993
Healthy People 2000. The rationale and potential efficacy of preventive nutrition in heart disease: the Framingham Offspring-Spouse Study
B M Posner, L A Cupples, D Gagnon, et al.
JAMA
|
March 2, 1990
How reliably can compact chemistry analyzers measure lipids?
H W Kaufman, J R McNamara, K M Anderson, et al.
The New England Journal of Medicine
|
November 5, 1987
Hip fracture and the use of estrogens in postmenopausal women. The Framingham Study
D P Kiel, D T Felson, J J Anderson, et al.
Journal of Lipid Research
|
April 1, 1987
Apolipoprotein E isoform phenotyping methodology and population frequency with identification of apoE1 and apoE5 isoforms
J M Ordovas, L Litwack-Klein, P W Wilson, et al.
American Heart Journal
|
September 1, 1990
Diabetes, fibrinogen, and risk of cardiovascular disease: the Framingham experience
W B Kannel, R B D'Agostino, P W Wilson, et al.
Archives of Internal Medicine
|
May 1, 1989
Is coffee consumption a contributor to cardiovascular disease? Insights from the Framingham Study
P W Wilson, R J Garrison, W B Kannel, et al.
Annals of Internal Medicine
|
June 10, 1998
Metabolic risk factors worsen continuously across the spectrum of nondiabetic glucose tolerance. The Framingham Offspring Study
J B Meigs, D M Nathan, P W Wilson, et al.
Diabetes
|
February 1, 1992
Association of HbA1c with prevalent cardiovascular disease in the original cohort of the Framingham Heart Study
D E Singer, D M Nathan, K M Anderson, et al.
Page
of 33